121
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Role of Cytokines Released During Pyroptosis in Non-Small Cell Lung Cancer

, , , ORCID Icon &
Pages 7399-7409 | Published online: 24 Sep 2021

References

  • KangR, ZhangQ, ZehHJ3rd, LotzeMT, TangD. HMGB1 in cancer: good, bad, or both?Clin Cancer Res. 2013;19(15):4046–4057. doi:10.1158/1078-0432.CCR-13-049523723299
  • Islas-VazquezL, Aguilar-CazaresD, Galicia-VelascoM, et al. IL-6, NLR, and SII markers and their relation with alterations in CD8+ T-lymphocyte subpopulations in patients treated for lung adenocarcinoma. Biology. 2020;9(11):376.
  • LuT, YangX, HuangY, et al. Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades. Cancer Manag Res. 2019;11:943–953. doi:10.2147/CMAR.S18731730718965
  • WangY, GaoW, ShiX, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547(7661):99–103. doi:10.1038/nature2239328459430
  • HinshawDC, ShevdeLA. The tumor microenvironment innately modulates cancer progression. Cancer Res. 2019;79(18):4557–4566. doi:10.1158/0008-5472.CAN-18-396231350295
  • LiuA, YangB. Roles of TRPM7 in renal ischemia-reperfusion injury. Curr Protein Pept Sci. 2019;20(8):777–788. doi:10.2174/138920372066619050710294831060485
  • SimpsonJ, LohZ, UllahMA, et al. Respiratory syncytial virus infection promotes necroptosis and HMGB1 release by airway epithelial cells. Am J Respir Crit Care Med. 2020;201(11):1358–1371. doi:10.1164/rccm.201906-1149OC32105156
  • VénéreauE, CeriottiC, BianchiME. DAMPs from cell death to new life. Front Immunol. 2015;6:422. doi:10.3389/fimmu.2015.0042226347745
  • ZhangZ, WangM, ZhouL, et al. Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer. J Exp Clin Cancer Res. 2015;34(1):51. doi:10.1186/s13046-015-0166-125986235
  • MorrisAB, FarleyCR, PinelliDF, et al. Signaling through the inhibitory Fc receptor FcγRIIB induces CD8+ T cell apoptosis to limit T cell immunity. Immunity. 2020;52(1):136–150.e6. doi:10.1016/j.immuni.2019.12.00631940267
  • ZhangZ, ZhangY, XiaS, et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature. 2020;579(7799):415–420. doi:10.1038/s41586-020-2071-932188940
  • WuM, WangY, YangD, et al. A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma. EbioMedicine. 2019;41:244–255. doi:10.1016/j.ebiom.2019.02.01230876762
  • LiuZ, ZhouQ, WangZ, et al. Intratumoral TIGIT+ CD8+ T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancer. J Immunother Cancer. 2020;8(2):e000978. doi:10.1136/jitc-2020-00097832817209
  • YangS, ThorAD, EdgertonS, YangX. caspase-3 mediated feedback activation of apical caspases in doxorubicin and TNF-alpha induced apoptosis. Apoptosis. 2006;11(11):1987–1997. doi:10.1007/s10495-006-0084-y17013758
  • PorterAG, JänickeRU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999;6(2):99–104. doi:10.1038/sj.cdd.440047610200555
  • WangYY, LiuXL, ZhaoR. Induction of pyroptosis and its implications in cancer management. Front Oncol. 2019;9:971. doi:10.3389/fonc.2019.0097131616642
  • FinkSL, CooksonBT. Pyroptosis and host cell death responses during salmonella infection. Cell Microbiol. 2007;9(11):2562–2570. doi:10.1111/j.1462-5822.2007.01036.x17714514
  • DingJ, WangK, LiuW, et al. Pore-forming activity and structural autoinhibition of the gasdermin family [publIshed correctIon appears In Nature. Nature. 2016;535(7610):111–116. doi:10.1038/nature1859027281216
  • AgliettiRA, DueberEC. Recent insights into the molecular mechanisms underlying pyroptosis and gasdermin family functions. Trends Immunol. 2017;38(4):261–271. doi:10.1016/j.it.2017.01.00328196749
  • MoossaviM, ParsamaneshN, BahramiA, AtkinSL, SahebkarA. Role of the NLRP3 inflammasome in cancer. Mol Cancer. 2018;17(1):158. doi:10.1186/s12943-018-0900-330447690
  • DunnJH, EllisLZ, FujitaM. Inflammasomes as molecular mediators of inflammation and cancer: potential role in melanoma. Cancer Lett. 2012;314(1):24–33. doi:10.1016/j.canlet.2011.10.00122050907
  • KarkiR, ManSM, KannegantiTD. Inflammasomes and cancer. Cancer Immunol Res. 2017;5(2):94–99. doi:10.1158/2326-6066.CIR-16-026928093447
  • SimsGP, RoweDC, RietdijkST, HerbstR, CoyleAJ. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol. 2010;28:367–388. doi:10.1146/annurev.immunol.021908.13260320192808
  • GaoQ, WangS, ChenX, et al. Cancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC. J Immunother Cancer. 2019;7(1):42. doi:10.1186/s40425-019-0511-630744691
  • TangD, KangR, LiveseyKM, et al. Endogenous HMGB1 regulates autophagy. J Cell Biol. 2010;190(5):881–892. doi:10.1083/jcb.20091107820819940
  • TangD, KangR, LiveseyKM, et al. High-mobility group box 1 is essential for mitochondrial quality control. Cell Metab. 2011;13(6):701–711. doi:10.1016/j.cmet.2011.04.00821641551
  • LangeSS, VasquezKM. HMGB1: the jack-of-all-trades protein is a master DNA repair mechanic. Mol Carcinog. 2009;48(7):571–580. doi:10.1002/mc.2054419360789
  • JiaoY, WangHC, FanSJ. Growth suppression and radiosensitivity increase by HMGB1 in breast cancer. Acta Pharmacol Sin. 2007;28(12):1957–1967. doi:10.1111/j.1745-7254.2007.00669.x18031610
  • VeselyMD, KershawMH, SchreiberRD, et al. Natural innate and adaptive immunity to cancer. Annu Rev Immunol. 2011;29:235–271. doi:10.1146/annurev-immunol-031210-10132421219185